Suppr超能文献

癌症护理中细胞、分子和基因组技术的卫生服务研究议程。

A health services research agenda for cellular, molecular and genomic technologies in cancer care.

作者信息

Wideroff Louise, Phillips Kathryn A, Randhawa Gurvaneet, Ambs Anita, Armstrong Katrina, Bennett Charles L, Brown Martin L, Donaldson Molla S, Follen Michele, Goldie Sue J, Hiatt Robert A, Khoury Muin J, Lewis Graham, McLeod Howard L, Piper Margaret, Powell Isaac, Schrag Deborah, Schulman Kevin A, Scott Joan

机构信息

National Cancer Institute, Bethesda, MD, USA.

出版信息

Public Health Genomics. 2009;12(4):233-44. doi: 10.1159/000203779. Epub 2009 Feb 20.

Abstract

BACKGROUND

In recent decades, extensive resources have been invested to develop cellular, molecular and genomic technologies with clinical applications that span the continuum of cancer care.

METHODS

In December 2006, the National Cancer Institute sponsored the first workshop to uniquely examine the state of health services research on cancer-related cellular, molecular and genomic technologies and identify challenges and priorities for expanding the evidence base on their effectiveness in routine care.

RESULTS

This article summarizes the workshop outcomes, which included development of a comprehensive research agenda that incorporates health and safety endpoints, utilization patterns, patient and provider preferences, quality of care and access, disparities, economics and decision modeling, trends in cancer outcomes, and health-related quality of life among target populations.

CONCLUSIONS

Ultimately, the successful adoption of useful technologies will depend on understanding and influencing the patient, provider, health care system and societal factors that contribute to their uptake and effectiveness in 'real-world' settings.

摘要

背景

近几十年来,已投入大量资源来开发具有临床应用价值的细胞、分子和基因组技术,这些技术贯穿癌症治疗的全过程。

方法

2006年12月,美国国立癌症研究所主办了首次研讨会,专门审视癌症相关细胞、分子和基因组技术的卫生服务研究状况,并确定在扩大其在常规治疗中有效性证据基础方面的挑战和优先事项。

结果

本文总结了研讨会成果,其中包括制定一项全面的研究议程,该议程纳入了健康与安全终点、利用模式、患者和提供者偏好、护理质量与可及性、差异、经济学和决策建模、癌症结局趋势以及目标人群中与健康相关的生活质量。

结论

最终,成功采用有用的技术将取决于理解并影响那些有助于在“现实世界”环境中采用这些技术并使其发挥效用的患者、提供者、医疗保健系统和社会因素。

相似文献

1
A health services research agenda for cellular, molecular and genomic technologies in cancer care.
Public Health Genomics. 2009;12(4):233-44. doi: 10.1159/000203779. Epub 2009 Feb 20.
2
Multilevel research and the challenges of implementing genomic medicine.
J Natl Cancer Inst Monogr. 2012 May;2012(44):112-20. doi: 10.1093/jncimonographs/lgs003.
3
Introduction: Understanding and influencing multilevel factors across the cancer care continuum.
J Natl Cancer Inst Monogr. 2012 May;2012(44):2-10. doi: 10.1093/jncimonographs/lgs008.
4
Reducing disparity in behavioral health services: a report from the American College of Mental Health Administration.
Adm Policy Ment Health. 2004 Jan;31(3):253-63. doi: 10.1023/b:apih.0000018833.22506.fc.
5
Translating genomics in cancer care.
J Natl Compr Canc Netw. 2013 Nov;11(11):1343-53. doi: 10.6004/jnccn.2013.0158.
6
7
Coordinating care and treatment for cancer patients.
Asian Pac J Cancer Prev. 2012;13(4 Suppl):23-36.
8
Advancing health disparities research within the health care system: a conceptual framework.
Am J Public Health. 2006 Dec;96(12):2113-21. doi: 10.2105/AJPH.2005.077628. Epub 2006 Oct 31.

引用本文的文献

1
Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium.
J Clin Transl Sci. 2021 Sep 14;5(1):e193. doi: 10.1017/cts.2021.855. eCollection 2021.
2
Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray.
Eur J Hum Genet. 2015 Sep;23(9):1135-41. doi: 10.1038/ejhg.2014.260. Epub 2014 Dec 10.
3
Rethinking our public health genetics research paradigm.
Am J Public Health. 2013 Oct;103 Suppl 1(Suppl 1):S14-8. doi: 10.2105/AJPH.2012.301127. Epub 2013 Aug 8.
5
Barriers to the use of personalized medicine in breast cancer.
J Oncol Pract. 2012 Jul;8(4):e24-31. doi: 10.1200/JOP.2011.000448. Epub 2012 May 22.
6
Treatment Choices Based on OncotypeDx in the Breast Oncology Care Setting.
J Cancer Epidemiol. 2012;2012:941495. doi: 10.1155/2012/941495. Epub 2012 Aug 13.
7
A population approach to precision medicine.
Am J Prev Med. 2012 Jun;42(6):639-45. doi: 10.1016/j.amepre.2012.02.012.
8
Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2105-14. doi: 10.1158/1055-9965.EPI-11-0481. Epub 2011 Jul 27.
9
Translational research in cancer genetics: the road less traveled.
Public Health Genomics. 2011;14(1):1-8. doi: 10.1159/000272897. Epub 2009 Dec 29.
10
Postal survey of physicians and laboratories: practices and perceptions of molecular oncology testing.
BMC Health Serv Res. 2009 Jul 30;9:131. doi: 10.1186/1472-6963-9-131.

本文引用的文献

2
CHAPTER 10 A public health approach to cervical cancer control: Considerations of screening and vaccination strategies.
Int J Gynaecol Obstet. 2006 Nov;94 Suppl 1:S95-S105. doi: 10.1016/S0020-7292(07)60016-2.
4
The changing physician workforce landscape: implications for physical medicine and rehabilitation.
Am J Phys Med Rehabil. 2007 Oct;86(10):838-44. doi: 10.1097/PHM.0b013e318156d7e7.
5
Translating pharmacogenomics: challenges on the road to the clinic.
PLoS Med. 2007 Aug;4(8):e209. doi: 10.1371/journal.pmed.0040209.
6
Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges.
Clin Pharmacol Ther. 2007 Oct;82(4):427-34. doi: 10.1038/sj.clpt.6100319. Epub 2007 Aug 8.
7
Applying the discovery of the Philadelphia chromosome.
J Clin Invest. 2007 Aug;117(8):2067-74. doi: 10.1172/JCI31988.
8
Functional imaging of cancer with emphasis on molecular techniques.
CA Cancer J Clin. 2007 Jul-Aug;57(4):206-24. doi: 10.3322/canjclin.57.4.206.
9
Brain imaging in neonatal clinical trials: in search of a gold standard.
J Pediatr. 2007 Jun;150(6):575-7. doi: 10.1016/j.jpeds.2007.04.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验